These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19775485)

  • 1. Are nasal decongestants safer than rhinitis? A case of oxymetazoline-induced syncope.
    Fabi M; Formigari R; Picchio FM
    Cardiol Young; 2009 Dec; 19(6):633-4. PubMed ID: 19775485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thunderclap headache and reversible segmental cerebral vasoconstriction associated with use of oxymetazoline nasal spray.
    Loewen AH; Hudon ME; Hill MD
    CMAJ; 2004 Sep; 171(6):593-4. PubMed ID: 15367461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bradycardia, hypotension, and near-syncope associated with Afrin (oxymetazoline) nasal spray.
    Glazener F; Blake K; Gradman M
    N Engl J Med; 1983 Sep; 309(12):731. PubMed ID: 6888446
    [No Abstract]   [Full Text] [Related]  

  • 4. [Investigation of the effect of oxymetazoline on the duration of rhinitis. results of a placebo-controlled double-blind study in patients with acute rhinitis].
    Reinecke S; Tschaikin M
    MMW Fortschr Med; 2005 Oct; 147 Suppl 3():113-8. PubMed ID: 16261947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal respiratory distress from rhinitis medicamentosa.
    Osguthorpe JD; Shirley R
    Laryngoscope; 1987 Jul; 97(7 Pt 1):829-31. PubMed ID: 2439862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical test of oxymetazoline-HCl-nose drops for infants (Nasivin 0,01 per cent)].
    Rüggeberg F
    Z Allgemeinmed; 1974 Apr; 50(11):535-7. PubMed ID: 4135074
    [No Abstract]   [Full Text] [Related]  

  • 7. A study of the effect of nasal steroid sprays in perennial allergic rhinitis patients with rhinitis medicamentosa.
    Ferguson BJ; Paramaesvaran S; Rubinstein E
    Otolaryngol Head Neck Surg; 2001 Sep; 125(3):253-60. PubMed ID: 11555762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.
    Graf P
    Rhinology; 1996 Mar; 34(1):9-13. PubMed ID: 8739860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.
    Watanabe H; Foo TH; Djazaeri B; Duncombe P; Mackay IS; Durham SR
    Rhinology; 2003 Sep; 41(3):167-74. PubMed ID: 14579657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tolerance and effectiveness of oxymetazoline and xylometazoline in treatment of acute rhinitis].
    Dorn M; Hofmann W; Knick E
    HNO; 2003 Oct; 51(10):794-9. PubMed ID: 14523532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-ST-elevation myocardial infarction with the use of oxymetazoline nasal spray.
    Rajpal S; Morris LA; Akkus NI
    Rev Port Cardiol; 2014 Jan; 33(1):51.e1-4. PubMed ID: 24405558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended use of topical nasal decongestants.
    Yoo JK; Seikaly H; Calhoun KH
    Laryngoscope; 1997 Jan; 107(1):40-3. PubMed ID: 9001263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxymetazoline-Induced Asthma.
    Shah S; Patel K; Gambhir HS
    Am J Ther; 2018; 25(6):e681-e682. PubMed ID: 28901959
    [No Abstract]   [Full Text] [Related]  

  • 14. Branch retinal artery occlusion after excessive use of nasal spray.
    Magargal LE; Sanborn GE; Donoso LA; Gonder JR
    Ann Ophthalmol; 1985 Aug; 17(8):500-1. PubMed ID: 2413795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apical ballooning syndrome secondary to nasal decongestant abuse.
    Wang R; Souza NF; Fortes JA; Santos GJ; Faria Neto JR; Zytinski L
    Arq Bras Cardiol; 2009 Nov; 93(5):e75-8. PubMed ID: 20084298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nasal decongestants and eye drops: keep out of children's reach!].
    Poulin-Chartrand S
    Perspect Infirm; 2013; 10(2):63. PubMed ID: 23539872
    [No Abstract]   [Full Text] [Related]  

  • 17. Nasal decongestant therapy.
    Stride RD
    Br J Clin Pract; 1967 Nov; 21(11):541-8. PubMed ID: 4169455
    [No Abstract]   [Full Text] [Related]  

  • 18. ["Of snakes and crocodiles": central side effects of nose drops and facts about rhinitis medicamentosa].
    Bielenberg J
    Kinderkrankenschwester; 2011 Oct; 30(10):406-8. PubMed ID: 22029138
    [No Abstract]   [Full Text] [Related]  

  • 19. Anterior ischemic optic neuropathy following the use of a nasal decongestant.
    Fivgas GD; Newman NJ
    Am J Ophthalmol; 1999 Jan; 127(1):104-6. PubMed ID: 9933016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of the effect of oxymetazoline on the duration of rhinitis].
    Reinecke S; Tschaikin M
    MMW Fortschr Med; 2005 Oct; 147(41):46. PubMed ID: 16270513
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.